ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 746

Impact of Nephritis on the Outcomes of SLE Patients Hospitalized with Acute Myocardial Infarction; Insights from the National Inpatient Sample Database

Atefeh Vafa1, Setri Fugar2, Chimezie Mbachi1 and John P. Case3,4, 1Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Cardiology, Rush University Medical Center, Chicago, IL, 3Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 4Internal Medicine, Chicago Medical School, North Chicago, IL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: SLE and lupus nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Early cardiovascular disease is an important cause of mortality in SLE. Previous studies have shown that lupus nephritis (LN) was associated with an increased risk of cardiovascular events in SLE patients. The primary aim of the present study was to assess the role of nephritis in mortality of SLE patients hospitalized with acute myocardial infarction (AMI) in a nationally representative sample.

Methods:

We used data from the National Inpatient Sample (NIS) for the period 2005-2015 with adult AMI as a primary diagnosis and SLE, nephritis, chronic kidney disease (CKD) and end-stage renal disease (ESRD) as secondary diagnoses using ICD-9 codes. There is no specific ICD-9 code for LN and its classes. The proportion who met ACR classification criteria cannot be determined with the NIS database.

We compared the characteristics of AMI hospitalizations in SLE patients with and without nephritis and used logistic regression to calculate the odds ratios for inpatient mortality from AMI in SLE patients with nephritis. We compared this to AMI in SLE patients with all kidney disease (AKD) (defined as having ESRD or CKD or nephritis) and without kidney disease. AKD in SLE population is most likely due to LN 1.

Results:

We identified a total of 4810 AMIs from 2005-2015 in patients with SLE. Among these, 245 had a discharge diagnosis of nephritis and 837 had AKD.

AMI hospitalizations with SLE and nephritis were younger (50.3 vs. 61.3 years; p<0.01) with a higher proportion of males (24.9% vs. 19%; p<0.05) and a higher proportion of African-Americans (36.7% vs. 22.3%; p<0.01) compared to patients with SLE without nephritis. The findings for SLE and AKD were similar: younger and with a higher proportion of males and African-Americans. The findings are summarized in the table.

The unadjusted inpatient mortality from AMI in SLE and nephritis was not statistically different from that in SLE patients without nephritis, even after adjusting for age, gender, race, comorbidities and invasive cardiac procedures (aOR=1.28; 95% CI=0.5-2.7; p=0.52). The adjusted odds-ratio for inpatient mortality from AMI in SLE and AKD, however, was 1.84 (95% CI=1.27-2.67; p<0.01).

Conclusion:

Patients with SLE and nephritis presented with AMI at a younger age compared to patients with SLE and no nephritis. The former group of SLE patients did not have a statistically different inpatient mortality due to AMI. However, AMI hospitalizations with SLE and AKD were associated with an increased probability of inpatient mortality compared to the ones with SLE and no kidney disease. Given that the most kidney diseases in SLE patients appear to be related to LN 1, this study suggests that LN is an independent risk factor for inpatient mortality due to AMI.

 

Variables*

SLE with nephritis vs. SLE without nephritis

SLE with AKD vs. SLE without kidney disease

Mean age (years)

50.3 vs. 61.3 (p <0.01)

57.6 vs. 61.4 (p <0.01)

Female percentage

75.1 vs. 81.0 (p <0.05)

75.9 vs. 81.7 (p <0.05)

Hypertension (%)

80.8 vs. 68.6 (p <0.01)

81.8 vs. 66.5 (p <0.01)

Complicated diabetes mellitus (%)

15.5 vs. 4.3 (p <0.01)

11.4 vs. 3.5 (p <0.01)

Anemia (%)

45.3 vs. 22.7 (p <0.01)

42.4 vs. 19.9 (p <0.01)

Non-ST elevation MI (%)

75.9 vs. 70.5 (p =0.06)

79.0 vs. 69.0 (p <0.01)

Percutaneous coronary intervention (%)

33.5 vs. 41.8 (p <0.01)

30.9 vs. 43.6 (p <0.01)

Coronary artery bypass graft (%)

3.7 vs. 7.0 (p <0.05)

6.6 vs. 6.9 (p =0.75)

Mean length of stay (days)

6.2 vs. 5.0 (p <0.01)

6.5 vs. 4.3 (p <0.01)

Mean total charges ($)

66717.7 vs. 66493.8 (p=0.96)

73320.5 vs. 65069.4 (p <0.01)

Unadjusted odds-ratio for inpatient mortality

1.24 (CI=0.72-2.12; p =0.43)

1.45 (CI=1.06-1.97; p <0.01)

Adjusted odds-ratio for inpatient mortality

1.28 (CI=0.59-2.77; p =0.52)

1.84 (CI=1.27-2.67; p <0.01)

*Demographic, Clinical Characteristics and outcomes of AMI hospitalizations in SLE patients with and without nephritis as well as SLE patients with and without all kidney disease.

Reference:

1. Plantinga LC, Drenkard C, Pastan SO, et al. Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry. Lupus Sci Med. 2016; 3(1): e000132.


Disclosure: A. Vafa, None; S. Fugar, None; C. Mbachi, None; J. P. Case, None.

To cite this abstract in AMA style:

Vafa A, Fugar S, Mbachi C, Case JP. Impact of Nephritis on the Outcomes of SLE Patients Hospitalized with Acute Myocardial Infarction; Insights from the National Inpatient Sample Database [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/impact-of-nephritis-on-the-outcomes-of-sle-patients-hospitalized-with-acute-myocardial-infarction-insights-from-the-national-inpatient-sample-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-nephritis-on-the-outcomes-of-sle-patients-hospitalized-with-acute-myocardial-infarction-insights-from-the-national-inpatient-sample-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology